ClinicalTrials.Veeva

Menu

Impact of Bevel Orientation on Arteriovenous Fistula Puncture in Hemodialysis (FAVORI)

C

Centre Hospitalier Emile Roux

Status

Not yet enrolling

Conditions

End-Stage Renal Disease Requiring Haemodialysis

Treatments

Procedure: Needle bevel orientation for arteriovenous fistula puncture

Study type

Interventional

Funder types

Other

Identifiers

NCT06708338
2024-A01536-41 (Other Identifier)
RIPH2_SOULIER_FAVORI

Details and patient eligibility

About

End-stage renal disease (ESRD) is a condition in which the filtration function of the kidneys has deteriorated, necessitating dialysis or transplantation. With an aging population, the number of patients undergoing dialysis for CKD is constantly increasing.

There are different types of dialysis treatment: hemodialysis and peritoneal dialysis.

Hemodialysis involves exchanges between blood and a dialysate (a liquid used to purify blood) via a dialyzer (artificial filter), coordinated by a generator. This method requires a vascular approach, of which there are 3 types: the arteriovenous fistula (AVF), the arteriovenous graft and the central venous catheter.

The AVF remains the vascular access of choice for hemodialysis sessions, and its preservation is an essential objective for patients with CKD.

One of the major challenges for AVFs is to achieve a successful puncture, an act performed around 310 times a year per patient, for dialysis performed three times a week with double needles. This repeated procedure can cause damage to the AVF, leading to complications such as stenosis, thrombosis, aneurysm, superficial infection, hematoma, bleeding, parietal rupture or dissection.

However, there is no official recommendation on the most conservative puncture technique for AVF. In view of the number of patients concerned and the recurrence of puncture, it would seem essential to evaluate the impact of bevel orientation on the occurrence of complications during dialysis by means of a randomized prospective study.

Enrollment

240 estimated patients

Sex

All

Ages

18 to 85 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • male or female with Chronic Kidney Disease
  • patient requiring 4-hour hemodialysis sessions, 3 times per week, in a dialysis center
  • Native arteriovenous fistula (AVF) (without prosthesis), mature, with no prior puncture, located in the upper limb
  • First fistula for a hemodialysis patient
  • Expected duration of dialysis ≥ 1 year
  • Double-needle dialysis
  • Hemodialysis possible on AVF
  • Average AVF flow rate between 500 and 2,000 mL/min
  • Affiliated with a social security scheme
  • Free and informed consent

Exclusion criteria

  • Auto-dialysis at home
  • Puncture using the buttonhole technique
  • Patient requiring AVF puncture with a catheter
  • Planned transplant within the next 12 months
  • Previous AVF creation, except for the fistula of interest
  • Patient with a history of cancer within the past 5 years or active cancer
  • Patient under court protection or guardianship
  • Pregnant and breast-feeding women
  • Patient with psychiatric pathologies or cognitive disorders
  • Patient follow-up difficult or impossible for geographical or other reasons, at the investigator's discretion

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

240 participants in 2 patient groups

Bevel-up group
Active Comparator group
Description:
AVF puncture will be performed with the needle bevel facing up for the entire duration of the patient's participation.
Treatment:
Procedure: Needle bevel orientation for arteriovenous fistula puncture
Bevel-down group
Experimental group
Description:
AVF puncture will be performed with the needle bevel facing down for the entire duration of the patient's participation
Treatment:
Procedure: Needle bevel orientation for arteriovenous fistula puncture

Trial contacts and locations

4

Loading...

Central trial contact

Camille FARCY; David SOULIER

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems